Precision BioSciences(DE:PBS0)
€7.62+0.49 (+6.87%)
DE:PBS0
Precision BioSciences financials statements
€7.62
At close:+0.49 (+6.87%)
Precision BioSciences (PBS0) Financial Statements
1 Followers
Precision BioSciences Financial Overview
Precision BioSciences's market cap is currently $263.85M. The company's EPS TTM is $-1.23; its P/E ratio is -7.87; Precision BioSciences is estimated to report earnings on March 18, 2027, and the estimated EPS forecast is $-0.63. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 34.26M | $ 68.70M | $ 48.73M | $ 25.10M | $ 115.53M |
| Gross Profit | $ 34.26M | $ 68.70M | $ 48.73M | $ 25.10M | $ 115.53M |
| Operating Income | $ -52.15M | $ -26.16M | $ -43.74M | $ -62.31M | $ -39.38M |
| EBITDA | $ -42.43M | $ 13.53M | $ -32.04M | $ -62.79M | $ -20.27M |
| Net Income | $ -45.72M | $ 7.17M | $ -61.32M | $ -111.64M | $ -30.60M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 115.58M | $ 86.31M | $ 116.68M | $ 189.58M | $ 143.66M |
| Total Assets | $ 154.42M | $ 136.39M | $ 159.78M | $ 238.17M | $ 211.50M |
| Total Debt | $ 28.81M | $ 30.05M | $ 31.27M | $ 24.96M | $ 9.11M |
| Net Debt | $ -82.02M | $ -55.85M | $ -85.41M | $ -164.62M | $ -134.55M |
| Total Liabilities | $ 62.17M | $ 80.00M | $ 140.92M | $ 177.74M | $ 120.33M |
| Stockholders' Equity | $ 92.25M | $ 56.39M | $ 18.86M | $ 60.43M | $ 91.17M |
| Cash Flow | |||||
| Free Cash Flow | $ -65.93M | $ -58.70M | $ -86.39M | $ -49.07M | $ -16.66M |
| Operating Cash Flow | $ -65.84M | $ -58.45M | $ -84.11M | $ -45.75M | $ -10.85M |
| Investing Cash Flow | $ -634.00K | $ -215.00K | $ 5.83M | $ -3.32M | $ -5.80M |
| Financing Cash Flow | $ 95.16M | $ 50.45M | $ 5.39M | $ 94.98M | $ 70.52M |
Currency in USD
